Glutamine nano preparation and its preparation method and application

By combining emulsifier and high-pressure homogenization technology, glutamine nanopreparations were prepared and protective films were formed using modified glucidin and soy lecithin, which solved the problem of storage and in vivo stability, improved bioavailability and hangover tablets. Relieve alcohol effect.

CN118766861BActive Publication Date: 2024-11-12SHANDONG QIYUAN BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411283717.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-13
Publication Date
2024-11-12
Estimated Expiration
2044-09-13

AI Technical Summary

Technical Problem

The prior art is difficult to simultaneously improve the storage stability and in vivo stability of glutamine nanoformulations, resulting in low bioavailability and poor efficacy.

Method used

Using emulsifiers such as caprylic acid decanoic acid polyethylene glycol glyceride, glycerol phosphate and glycerol monolaurate, glutamine nanoformulations are prepared by high-pressure homogenization and spray drying technology, and using modified gliadin and soybean Lecithin forms a protective film, enhancing the stability and targeting of nanoformulations.

Benefits of technology

It significantly improves the storage stability and in vivo stability of glutamine, enhances bioavailability and targeting, reduces the degradation of drugs in the body, improves absorption efficiency, and shows good hangover in hangover tablets Effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present invention discloses a glutamine nano preparation and its preparation method and application, mainly relating to the field of amide technology. The glutamine nano preparation in the present invention comprises the following components: glutamine, modified gliadin, soy lecithin, glycerol, and emulsifier. Compared with the prior art, the storage stability and in vivo stability of the glutamine nano preparation are improved, and high absorption rate and high bioavailability are achieved. The present invention applies the glutamine nano preparation to alcohol-relieving tablets. Glutamine produces α-ketoglutaric acid through metabolism, and then participates in the tricarboxylic acid cycle to generate NADH. NADH is oxidized in the mitochondria of cells to generate NAD+ and ATP, which helps to reactivate the metabolism of ethanol and acetaldehyde in the liver, avoids the accumulation of acetaldehyde to produce toxicity, and helps to recover quickly after a hangover. The present invention applies the glutamine nano preparation to alcohol-relieving tablets, which has a good alcohol-relieving effect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of amides, and in particular to a glutamine nano preparation and a preparation method and application thereof. Background Art

[0002] Glutamine is usually taken in the form of supplements, which can be taken in the form of powder, granules, tablets, capsules, injections, etc. Glutamine can be used to treat gastric and duodenal ulcers, gastritis and hyperacidity, and is also used to improve brain function; during exercise and disease recovery, due to the increased demand for glutamine in muscles, supplementation with glutamine can help promote muscle synthesis and reduce muscle breakdown; glutamine can serve as an important energy source for white blood cells and lymphocytes, helping to enhance the body's immune response; in intestinal cells, glutamine is essential for maintaining intestinal barrier function and promoting the repair and regeneration of intestinal cells.

[0003] Glutamine nanoformulation is a drug delivery system prepared using nanotechnology, which involves encapsulating glutamine in a nano-sized carrier, which can be a liposome, polymer nanoparticle or other type of nanostructure. Nanoformulations can improve the solubility, stability, bioavailability and targeting of glutamine, thereby enhancing its absorption and efficacy in the body, improving the efficacy of the drug and reducing side effects. In terms of storage stability, for example, nanosuspensions can reduce the aggregation and sedimentation of glutamine during storage, which can improve its physical stability; nanoformulations can enhance the uptake of glutamine in specific cells or tissues through surface modification and the combination of targeting ligands; using surfactants as stabilizers can reduce the aggregation of nanoparticles and improve their stability under different conditions. In terms of in vivo stability, after taking it, it needs to pass through the stomach and then reach the duodenum or the upper part of the small intestine for absorption. Nanoformulations can protect glutamine from decomposition by digestive enzymes and specify the preparation to be absorbed in the intestine through the specific surface characteristics of nanoparticles, thereby improving the bioavailability of glutamine; it can also promote the diffusion and absorption of drugs in the intestine, reduce the degradation of drugs in the body, and further improve the absorption efficiency.

[0004] CN115177593A discloses a glutamine granule and a preparation method thereof. The glutamine granule is composed of glutamine, a binder, a lubricant and a flow aid. The mass percentage content of each component in the granule is 70%-85% of glutamine, 10-30% of binder, 1-2% of lubricant and 1-2% of flow aid. The preparation method comprises the following steps: (1) screening; (2) mixing; (3) dry granulation; (4) screening. The invention has the advantages of simple prescription, rapid dissolution, good stability, simple preparation process, easy operation, time saving and energy saving, and is suitable for large-scale industrial production.

[0005] CN105085612A discloses N-(2)-L-alanyl-L-glutamine compounds and preparations prepared by particle crystal morphology optimization technology, which have the characteristics of high purity, high yield, low hygroscopicity and good stability. The invention also discloses a pharmaceutical composition prepared by alanyl glutamine in the present invention, wherein the pharmaceutical composition is prepared by alanyl glutamine into an aqueous solution with a concentration of 10% to 30%, adsorbed by medicinal activated carbon with a liquid dosage of 0.1% to 0.5% (w / v), then freeze-dried in large plates, and aseptically packaged. The entire preparation process is simple to operate, does not require any excipients, and has better stability than previous products.

[0006] The solutions reported in the above patent documents can solve the storage stability in vitro, but do not solve the in vivo stability problem at the same time. Poor in vivo stability will directly lead to low bioavailability and affect the effect. Therefore, in actual use, it is imperative to provide a glutamine preparation that is stable both in vitro and in vivo. Summary of the invention

[0007] In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to improve the storage stability and in vivo stability of glutamine nanoformulations and achieve high absorption rate and high bioavailability.

[0008] To achieve the above object, the present invention provides a glutamine nano preparation and a preparation method and application thereof.

[0009] The preparation method of the glutamine nano preparation comprises the following steps, measured in parts by weight:

[0010] Step (1), dissolving 0.5-1.5 parts of an emulsifier in 4-8 parts of anhydrous ethanol, stirring at 60-80° C. for 0.5-1 hour to obtain an emulsifier ethanol solution;

[0011] Step (2), adding 150-250 parts of gliadin to 1500-2500 parts of 60-80wt% ethanol aqueous solution and stirring for 0.5-1 hour, adding 80-120 parts of polypropylene glycol diglycidyl ether, continuing stirring for 4-6 hours, adding 200-300 parts of N-acetylglucosamine aqueous solution, continuing stirring for 4-6 hours, and finally placing in a dialysis bag for dialysis for 12-48 hours, and freeze-drying to obtain modified gliadin;

[0012] Step (3), dissolving 200-300 parts of modified gliadin in 2000-3000 parts of 60-80wt% ethanol aqueous solution, mixing with 800-1200 parts of glutamine-water solution, stirring at room temperature for 0.5-1 hour to obtain a mixed suspension solution, adding 8-15 parts of phospholipids, 4-8 parts of emulsifier ethanol solution, and 250-350 parts of glycerol to the mixed suspension solution, stirring at 60-80°C for 1-2 hours until the emulsification is uniform, processing by a high-pressure homogenizer 2-4 times, and finally spray drying to obtain the glutamine nano preparation.

[0013] In the step (1), the emulsifier is any one or more of caprylic / capric macrogol glyceride, glyceryl phosphate, and glyceryl monolaurate.

[0014] The N-acetylglucosamine aqueous solution in step (2) is a 5-10wt% N-acetylglucosamine aqueous solution.

[0015] The glutamine-water solution in step (3) is 15-25 wt % glutamine-water solution.

[0016] The phospholipid in step (3) is soybean lecithin.

[0017] In step (3), the processing parameters of the high pressure homogenizer are 600-1000 bar.

[0018] The particle size of the glutamine nanoparticle preparation in step (3) is 20-50 nm.

[0019] Glutamine provides amino acids as the main active ingredient, which helps to improve intestinal health, enhance immunity and promote protein synthesis. The present invention prepares glutamine into a nano preparation, and what needs to be solved is the storage stability and in vivo stability problem, which has a promoting effect on improving its bioavailability and stability, and enhancing its targeting and sustained release effect in vivo. The added emulsifier includes caprylic acid capric acid macrogol glyceride, glycerophosphate and monolaurin, which helps to reduce the tension of the oil-water interface during the preparation process, promotes the mixing of lipids and water phases, forms a stable and uniform emulsified system, ensures the effective mixing of glutamine and liposome materials, provides a good foundation for the subsequent steps of high-pressure homogenization and spray drying, and helps to form a uniform and stable nano-scale liposome structure. Soy lecithin, as a kind of phospholipid, is an important component of liposome carriers. It not only helps to form the double-layer membrane structure of liposomes, but also has amphiphilicity, that is, it contains a hydrophilic phosphate group and two hydrophobic long-chain fatty acids in the molecule, which can attract both aqueous and oily phase solutions, improve the texture and compatibility of the emulsified solution, and ultimately improve the stability of liposomes and the encapsulation rate of glutamine. Glycerol, as a small molecule polyol, can form hydrogen bonds with water molecules, thereby increasing the viscosity of the aqueous phase, helping to stabilize the emulsification process, reducing the aggregation and merging of emulsion droplets, improving the physical properties of liposomes, and enhancing the moisture retention and stability of liposomes. Gliadin has a wide source and low cost, and has good biocompatibility, hydrophobicity, micropolarity, adhesiveness, and the ability to modify, enhance and target the release of functional ingredients. The invention cross-links gliadin and N-acetylglucosamine through polypropylene glycol diglycidyl ether to form modified gliadin, retains the film-forming property and adsorption property of gliadin itself, can form a protective film between the surface of glutamine and the liposome carrier, plays a role in slow release and protection of glutamine, enhances the in vivo stability and targeting of the nano preparation, makes it not easily decomposed by digestive enzymes, and thus improves the bioavailability.

[0020] The present invention also discloses the application of the above glutamine nano preparation in the preparation of alcohol sobering tablets. The specific application is as follows:

[0021] The hangover-relieving tablet is made by pressing the following raw materials: the glutamine nano preparation, a filler, a binder, a sweetener and a lubricant. The specific preparation method is:

[0022] The glutamine nano preparation, filler, adhesive, sweetener and lubricant are mixed evenly and tableted to obtain the alcohol sobering tablet.

[0023] The filler is hydroxypropyl methylcellulose.

[0024] The binder is microcrystalline cellulose.

[0025] The sweetener is sorbitol.

[0026] The lubricant is magnesium stearate.

[0027] Glutamine can quickly replenish the coenzyme NAD+ consumed in the liver during metabolism. This coenzyme is crucial in the metabolic pathways of ethanol and acetaldehyde. The rapid consumption of NAD+ will cause ethanol and acetaldehyde to accumulate in the liver and cannot be effectively decomposed, thus causing a state of drunkenness and potential toxicity to the liver. Glutamine produces α-ketoglutarate through metabolism, and then participates in the tricarboxylic acid cycle to generate NADH. NADH is oxidized in the mitochondria of the cell to generate NAD+ and ATP, which helps to reactivate the metabolism of ethanol and acetaldehyde in the liver, avoid the accumulation of acetaldehyde and produce toxicity, and help to recover quickly after a hangover. The present invention uses glutamine nano-preparation in alcohol-detoxifying tablets to have a good alcohol-detoxifying effect.

[0028] Beneficial effects of the present invention:

[0029] 1. Improve storage stability: Different emulsifiers have different molecular structures and hydrophilic-lipophilic balance values ​​(HLB values). Different combinations of emulsifiers may lead to differences in emulsification degree, emulsification efficiency, and oil-water interfacial tension, thereby affecting the particle size, structural stability, distribution uniformity, and encapsulation rate of the liposome. The emulsifiers in the present invention include caprylic acid capric acid macrogol glyceride, glycerophosphate, and monolaurin. The uniform emulsification system ensures the effective mixing of glutamine and liposome materials, making the combination of glutamine and liposome carriers tighter, so that the stability is not easily destroyed, reducing the effect of storage time on the activity of glutamine.

[0030] 2. Improve in vivo stability: Glutamine nanoparticles protect glutamine, slowing down the contact and decomposition of glutamine by digestive enzymes in gastric juice, reducing drug degradation in the body, and allowing glutamine to reach intestinal cells more effectively, ultimately increasing the absorption rate of glutamine in the body, thereby improving its bioavailability.

[0031] 3. The present invention uses glutamine nano preparations in hangover-relief tablets to achieve good hangover-relief effects, which helps to reactivate the metabolism of ethanol and acetaldehyde in the liver, avoid acetaldehyde accumulation and toxicity, and help to quickly recover from a hangover. DETAILED DESCRIPTION

[0032] The parameters of the specific chemical substances used in the examples are from the following sources:

[0033] Caprylic / capric macrogol glyceride: The manufacturer is Hubei Qifei Pharmaceutical Chemical Co., Ltd., and the product number is QF7716.

[0034] Glycerol phosphate: The manufacturer is Hubei Darli Chemical Co., Ltd., and the model is Darl-1.

[0035] Soy lecithin: The manufacturer is Shaanxi Xintianyu Biotechnology Co., Ltd., and the product number is XTY008.

[0036] Glycerin: The manufacturer is Jinan Jumeihui Chemical Co., Ltd., model is HGGGD.

[0037] Gliadin: The manufacturer is Hubei Baidu Chemical Co., Ltd., and the product number is BD0462.

[0038] Polypropylene glycol diglycidyl ether: The manufacturer is Hubei Xinhongli Chemical Co., Ltd., and the product number is XHL5025.

[0039] N-acetylglucosamine: The manufacturer is Wuhan Xinxinjiali Biotechnology Co., Ltd., and the product number is N21502.

[0040] Embodiment 1,

[0041] A method for preparing a glutamine nano preparation comprises the following steps:

[0042] Dissolve 0.5 g of caprylic acid capric acid macrogol glyceride in 4 g of anhydrous ethanol and stir at 60° C. for 1 hour to obtain an emulsifier ethanol solution;

[0043] 150 g of gliadin was added to 1500 g of 60 wt% ethanol aqueous solution and stirred for 0.5 hour, 80 g of polypropylene glycol diglycidyl ether was added and stirring was continued for 4 hours, 200 g of 5 wt% N-acetylglucosamine aqueous solution was added and stirring was continued for 4 hours, and finally the solution was placed in a dialysis bag with a molecular weight cutoff of 50000 D and dialyzed for 12 hours, and freeze-dried to obtain modified gliadin;

[0044] (3) 200 g of modified gliadin was dissolved in 2000 g of 60 wt% ethanol aqueous solution, mixed with 800 g of 15 wt% glutamine-water solution, and stirred at room temperature for 0.5 hour to obtain a mixed suspension solution, to which 10 g of soybean lecithin, 6 g of emulsifier ethanol solution, and 300 g of glycerol were added, and the mixture was stirred at 70° C. for 1.5 hours until the emulsification was uniform, and the mixture was treated by a high-pressure homogenizer for 3 times under a pressure of 800 bar, and finally the glutamine nanoformulation was obtained by spray drying, and the particle size thereof was 34 nm as measured by a laser particle size analyzer.

[0045] Embodiment 2,

[0046] A method for preparing a glutamine nano preparation comprises the following steps:

[0047] Dissolve 1.5 g of glycerophosphate in 8 g of anhydrous ethanol and stir at 80°C for 0.5 hour to obtain an emulsifier ethanol solution;

[0048] (2) Add 250 g of gliadin to 2500 g of 80 wt% ethanol aqueous solution and stir for 1 hour, add 120 g of polypropylene glycol diglycidyl ether and continue stirring for 6 hours, add 300 g of 10 wt% N-acetylglucosamine aqueous solution and continue stirring for 6 hours, finally put it into a dialysis bag with a molecular weight cutoff of 50000D and dialyze for 48 hours, and freeze-dry to obtain modified gliadin;

[0049] (3) 300 g of modified gliadin was dissolved in 3000 g of 80 wt% ethanol aqueous solution, mixed with 1200 g of 25 wt% glutamine-water solution, stirred at room temperature for 1 hour to obtain a mixed suspension solution, 15 g of soybean lecithin, 8 g of emulsifier ethanol solution and 350 g of glycerol were added thereto, stirred at 80° C. for 2 hours until the emulsification was uniform, processed twice by a high-pressure homogenizer under a pressure of 800 bar, and finally spray-dried to obtain the glutamine nanoformulation, the particle size of which was 33 nm as measured by a laser particle size analyzer.

[0050] Embodiment 3,

[0051] A method for preparing a glutamine nano preparation comprises the following steps:

[0052] Dissolve 0.5 g of caprylic acid capric acid macrogol glyceride and 0.5 g of monolaurin in 6 g of anhydrous ethanol, and stir at 70° C. for 0.5 hour to obtain an emulsifier ethanol solution;

[0053] (2) Add 200 g of gliadin to 2000 g of 70 wt% ethanol aqueous solution and stir for 0.5 hour, add 100 g of polypropylene glycol diglycidyl ether and continue stirring for 5 hours, add 200 g of 8 wt% N-acetylglucosamine aqueous solution and continue stirring for 5 hours, finally put it into a dialysis bag with a molecular weight cutoff of 50,000 D and dialyze it for 24 hours, and then freeze-dry to obtain modified gliadin.

[0054] (3) 250 g of modified gliadin was dissolved in 2000 g of 70 wt% ethanol aqueous solution, mixed with 1000 g of 20 wt% glutamine-water solution, and stirred at room temperature for 0.5 hour to obtain a mixed suspension solution, to which 10 g of soybean lecithin, 6 g of emulsifier ethanol solution, and 300 g of glycerol were added, and the mixture was stirred at 70° C. for 1.5 hours until the emulsification was uniform, and the mixture was treated by a high-pressure homogenizer for 3 times under a pressure of 800 bar, and finally the glutamine nanoformulation was obtained by spray drying, and the particle size thereof was 33 nm as measured by a laser particle size analyzer.

[0055] Embodiment 4,

[0056] A method for preparing a glutamine nano preparation comprises the following steps:

[0057] Dissolve 0.5 g of monolaurin and 0.5 g of glycerol phosphate in 6 g of anhydrous ethanol, and stir at 70° C. for 0.5 hour to obtain an emulsifier ethanol solution;

[0058] (2) Add 200 g of gliadin to 2000 g of 70 wt% ethanol aqueous solution and stir for 0.5 hour, add 100 g of polypropylene glycol diglycidyl ether and continue stirring for 5 hours, add 200 g of 8 wt% N-acetylglucosamine aqueous solution and continue stirring for 5 hours, finally put it into a dialysis bag with a molecular weight cutoff of 50,000 D and dialyze it for 24 hours, and then freeze-dry to obtain modified gliadin.

[0059] (3) 250 g of modified gliadin was dissolved in 2000 g of 70 wt% ethanol aqueous solution, mixed with 1000 g of 20 wt% glutamine-water solution, and stirred at room temperature for 0.5 hour to obtain a mixed suspension solution, to which 10 g of soybean lecithin, 6 g of emulsifier ethanol solution, and 300 g of glycerol were added, and the mixture was stirred at 70° C. for 1.5 hours until the emulsification was uniform, and the mixture was treated by a high-pressure homogenizer for 3 times under a pressure of 800 bar, and finally the glutamine nanoformulation was obtained by spray drying, and the particle size thereof was 32 nm as measured by a laser particle size analyzer.

[0060] Embodiment 5,

[0061] A method for preparing a glutamine nano preparation comprises the following steps:

[0062] Dissolve 0.5 g of caprylic acid capric acid macrogol glyceride and 0.5 g of glycerophosphate in 6 g of anhydrous ethanol, and stir at 70° C. for 0.5 hour to obtain an emulsifier ethanol solution;

[0063] (2) Add 200 g of gliadin to 2000 g of 70 wt% ethanol aqueous solution and stir for 0.5 hour, add 100 g of polypropylene glycol diglycidyl ether and continue stirring for 5 hours, add 200 g of 8 wt% N-acetylglucosamine aqueous solution and continue stirring for 5 hours, finally put it into a dialysis bag with a molecular weight cutoff of 50,000 D and dialyze it for 24 hours, and then freeze-dry to obtain modified gliadin.

[0064] (3) 250 g of modified gliadin was dissolved in 2000 g of 70 wt% ethanol aqueous solution, mixed with 1000 g of 20 wt% glutamine-water solution, and stirred at room temperature for 0.5 hour to obtain a mixed suspension solution, to which 8 g of soybean lecithin, 4 g of emulsifier ethanol solution, and 250 g of glycerol were added, and the mixture was stirred at 70° C. for 1.5 hours until the emulsification was uniform, and the mixture was treated by a high-pressure homogenizer for 3 times under a pressure of 800 bar, and finally the glutamine nanoformulation was obtained by spray drying, and the particle size thereof was 33 nm as measured by a laser particle size analyzer.

[0065] Embodiment 6,

[0066] A method for preparing a glutamine nano preparation comprises the following steps:

[0067] Dissolve 0.33 g of caprylic acid capric acid macrogol glyceride, 0.33 g of glyceryl phosphate, and 0.34 g of monolaurin in 6 g of anhydrous ethanol, and stir at 70° C. for 0.5 hour to obtain an emulsifier ethanol solution;

[0068] (2) Add 200 g of gliadin to 2000 g of 70 wt% ethanol aqueous solution and stir for 0.5 hour, add 100 g of polypropylene glycol diglycidyl ether and continue stirring for 5 hours, add 200 g of 8 wt% N-acetylglucosamine aqueous solution and continue stirring for 5 hours, finally put it into a dialysis bag with a molecular weight cutoff of 50,000 D and dialyze it for 24 hours, and then freeze-dry to obtain modified gliadin.

[0069] (3) 250 g of modified gliadin was dissolved in 2000 g of 70 wt% ethanol aqueous solution, mixed with 1000 g of 20 wt% glutamine-water solution, and stirred at room temperature for 0.5 hour to obtain a mixed suspension solution, to which 10 g of soybean lecithin, 6 g of emulsifier ethanol solution, and 300 g of glycerol were added, and the mixture was stirred at 70° C. for 1.5 hours until the emulsification was uniform, and the mixture was treated by a high-pressure homogenizer for 3 times under a pressure of 800 bar, and finally the glutamine nanoformulation was obtained by spray drying, and the particle size thereof was 32 nm as measured by a laser particle size analyzer.

[0070] Embodiment 7,

[0071] A method for preparing a glutamine nano preparation comprises the following steps:

[0072] (1) Dissolve 0.5 g of caprylic acid capric acid polyethylene glycol glyceride and 0.5 g of glycerophosphate in 6 g of anhydrous ethanol and stir at 70° C. for 0.5 hour to obtain an emulsifier ethanol solution;

[0073] (2) Add 200 g of gliadin to 2000 g of 70 wt% ethanol aqueous solution and stir for 0.5 hour, add 100 g of polypropylene glycol diglycidyl ether and continue stirring for 5 hours, add 200 g of 8 wt% N-acetylglucosamine aqueous solution and continue stirring for 5 hours, finally put it into a dialysis bag with a molecular weight cutoff of 50,000 D and dialyze it for 24 hours, and then freeze-dry to obtain modified gliadin.

[0074] (3) 250 g of modified gliadin was dissolved in 2000 g of 70 wt% ethanol aqueous solution, mixed with 1000 g of 20 wt% glutamine-water solution, and stirred at room temperature for 0.5 hour to obtain a mixed suspension solution, to which 10 g of soybean lecithin, 5 g of emulsifier ethanol solution, and 280 g of glycerol were added, and the mixture was stirred at 60° C. for 1 hour until the emulsification was uniform, and the mixture was treated by a high-pressure homogenizer for 4 times under a pressure of 800 bar, and finally the glutamine nanoformulation was obtained by spray drying, and the particle size thereof was 30 nm as measured by a laser particle size analyzer.

[0075] Embodiment 8,

[0076] A method for preparing a glutamine nano preparation comprises the following steps:

[0077] Dissolve 0.5 g of caprylic acid capric acid macrogol glyceride and 0.5 g of glycerophosphate in 6 g of anhydrous ethanol, and stir at 70° C. for 0.5 hour to obtain an emulsifier ethanol solution;

[0078] (2) Add 200 g of gliadin to 2000 g of 70 wt% ethanol aqueous solution and stir for 0.5 hour, add 100 g of polypropylene glycol diglycidyl ether and continue stirring for 5 hours, add 200 g of 8 wt% N-acetylglucosamine aqueous solution and continue stirring for 5 hours, finally put it into a dialysis bag with a molecular weight cutoff of 50,000 D and dialyze it for 24 hours, and then freeze-dry to obtain modified gliadin.

[0079] (3) 250 g of modified gliadin was dissolved in 2000 g of 70 wt% ethanol aqueous solution, mixed with 1000 g of 20 wt% glutamine-water solution, and stirred at room temperature for 0.5 hour to obtain a mixed suspension solution, to which 12 g of soybean lecithin, 6 g of emulsifier ethanol solution, and 300 g of glycerol were added, and the mixture was stirred at 80° C. for 2 hours until the emulsification was uniform, and the mixture was treated by a high-pressure homogenizer at a pressure of 800 bar for 4 times, and finally spray-dried to obtain the glutamine nanoformulation, and the particle size thereof was 32 nm as measured by a laser particle size analyzer.

[0080] Comparative Example 1

[0081] A method for preparing a glutamine nano preparation comprises the following steps:

[0082] 10 g of soybean lecithin and 300 g of glycerol were added to 1000 g of a 20 wt% glutamine-water solution, and the mixture was stirred at 70° C. for 1.5 hours until the mixture was uniformly emulsified. The mixture was treated by a high-pressure homogenizer for 3 times under a pressure of 800 bar, and finally spray-dried to obtain the glutamine nanoformulation, the particle size of which was 33 nm as measured by a laser particle size analyzer.

[0083] Test Example 1:

[0084] Storage stability test

[0085] Take 5 groups of glutamine nanoformulations prepared in Examples 1-8 and Comparative Example 1 as test samples, and test the storage stability. The test samples were placed in an open box, and the box was stored at room temperature and pressure. The test was carried out at 25°C and 60% humidity. The content of the glutamine nanoformulation was tested at 0, 6, 12, and 24 months, and (content change difference / initial content) × 100% was calculated. The content value in the 0th month was the initial content. The data is summarized as described in Table 1, and the test data is averaged;

[0086]

[0087] In the stability test of Test Example 1, the difference between Examples 1-8 is the different selection of emulsifiers, and the difference from Comparative Example 1 to 8 is that no emulsifier is added to Comparative Example 1, and the aqueous phase solvent and the oil phase solvent are directly mixed in Comparative Example 1, resulting in low emulsification and poor dispersion uniformity between glutamine and the oil phase solvent, and loose combination of glutamine and other components. After subsequent high-pressure homogenization and drying treatments, the carrier loading rate of the glutamine nanoformulation is low, which ultimately makes the storage stability of the overall glutamine nanoformulation lower than that of the embodiment test group with the addition of an emulsifier. Emulsifiers are used to improve the uniformity of the dispersion of the oil-water phase and form a stable emulsified system. Different emulsifiers have different molecular structures and hydrophilic-lipophilic balance values ​​(HLB values); the emulsifier in Example 1 is caprylic acid capric acid polyethylene glycol glyceride, the emulsifier in Example 2 is glycerophosphate, and the compound of caprylic acid capric acid polyethylene glycol glyceride and monolauric acid glyceride in Example 3 is used as an emulsifier, and the compound of glycerophosphate and monolauric acid glyceride in Example 4 is used as an emulsifier. The difference in effect between the two is small, but both are better than the single emulsifier in Examples 1-2. Example 5 uses caprylic acid capric acid polyethylene glycol glyceride and glycerophosphate in combination, and the content changes less, indicating that glutamine is more tightly combined with the liposome carrier, so the stability is not easily destroyed. Example 6 uses emulsifiers together, and does not show a technical effect higher than that of Example 5, indicating that different combinations of emulsifiers may lead to differences in emulsification degree, emulsification efficiency, and oil-water interfacial tension, thereby affecting the particle size, distribution uniformity, and encapsulation rate of the liposome. Example 7-8 is the same as Example 5, where caprylic acid capric acid polyethylene glycol glyceride and glycerol phosphate are compounded for use, but the ratio of modified gliadin, soybean lecithin, emulsifier ethanol solution, and glycerol is adjusted, and the effect is better than that of Example 5.

[0088] Test Example 2:

[0089] In vivo stability testing

[0090] After being taken, glutamine nanoformulations need to pass through the stomach and then reach the duodenum or the upper part of the small intestine for absorption. If they are broken down by the digestive enzymes in the gastric juice, they will not be able to completely reach the intestinal surface, thus reducing the bioavailability and absorption efficiency of glutamine. Nanoformulations can protect glutamine from being broken down by digestive enzymes and specify the preparations to be absorbed in the intestine through the specific surface characteristics of nanoparticles, thereby improving the bioavailability of glutamine, and reducing the degradation of drugs in the body by promoting the diffusion and absorption of drugs in the intestine, thereby further improving the absorption efficiency.

[0091] Pepsin is a digestive enzyme, mainly secreted by gastric parietal cells, which can decompose protein in food and help decompose starch in food. In this test example, the glutamine nanoformulation prepared in Examples 5, 7-8 is used as a test sample, and each group of samples is subjected to HPLC content detection before the test, that is, the initial content. 1 mg of glutamine nanoformulation is added to 1 mL of water to obtain a suspension, and 1 mL of the suspension is added to 4 mL of artificial gastric juice, and incubated at 100 rpm at 37 ° C. 200 μL of samples are taken at 10, 30, and 60 minutes, added to 200 μL of methanol, diluted with water to make 1 mL, and the residual glutamine content is determined by HPLC, and (content change difference / initial content) × 100% is calculated. That is, after simulating the glutamine nanoformulation in the gastric juice environment after taking it, observe whether it is decomposed by the digestive enzymes in the gastric juice at 10, 30, and 60 minutes, so as to judge the in vivo stability of the glutamine nanoformulation, and the data are summarized as described in Table 2.

[0092] The preparation method of artificial gastric juice is as follows: take dilute hydrochloric acid with a concentration of 1 mol / mL, dilute with water, adjust the pH to 1.5, add 1 g of pepsin per 100 ml of liquid, mix well, filter with a 0.2 μm sterile filter head for use;

[0093]

[0094] Test Example 2 The glutamine nanoformulations obtained by the preparation methods of Examples 5, 7, and 8 were subjected to stability tests in a simulated gastric fluid environment. The modified gliadin added in Examples 5, 7, and 8 made the degradation rate of the glutamine nanoliposomes in a simulated gastric fluid environment lower than that of Comparative Example 1, thereby maintaining stability for a longer time in the body, reducing the loss in the stomach, and more effectively reaching the intestine and being absorbed, thereby improving the bioavailability of glutamine and the overall in vivo stability. Based on Example 5, Examples 7-8 adjusted the ratio of modified gliadin, soy lecithin, emulsifier ethanol solution, and glycerol to further improve the bioavailability of glutamine and the overall in vivo stability.

[0095] Test Example 3:

[0096] The glutamine nano preparation obtained by the preparation method of Example 1-8 was prepared into hangover-relieving tablets 1-8 according to the following steps. The specific steps are: 670g of glutamine nano preparation, 15g of hydroxypropyl methylcellulose, 200g of microcrystalline cellulose, 100g of sorbitol, and 15g of magnesium stearate were mixed evenly, and tableted at 2g / tablet to obtain the hangover-relieving tablets.

[0097] Alcohol detoxification test: 100 healthy mice weighing 20-22g were randomly divided into 10 groups, 10 mice in each group, corresponding to the blank group, model group and Example 1-8 test group, wherein the blank group did not drink alcohol, and the model group and Example 1-8 test group drank the same amount of alcohol, except that the model group did not take alcohol detoxification tablets. The blank group was gavaged with normal saline at a dose of 0.16mL / 10gBW; the model group and the test group were gavaged with 52-degree liquor at a dose of 0.16mL / 10gBW; and then the alcohol detoxification tablets 1-8 were dissolved in 20mL of water and gavaged with a dose of 0.16mL / 10gBW for the test group. Whether the mouse is drunk or not is based on the disappearance of the righting reflex as an indicator, that is, the mouse is gently placed in the animal cage with its back down. If the supine position is maintained for more than 30s, the righting reflex is considered to be lost. Observe and record the time of drunkenness and sobering up of the mouse. The blood ethanol concentration of the model group and the test group of Example 1-8 4 hours after the liquor gavage is shown in Table 4.

[0098] The results showed that compared with the simulation group, after the test groups of Examples 1-8 took the hangover-relieving tablets, the drunkenness time of the mice was prolonged and the sobering time was shortened, indicating that the hangover-relieving tablets 1-8 obtained by applying the glutamine nano-preparation of the present invention had a good hangover-relieving effect; as shown in Table 3;

[0099]

[0100] The preferred specific embodiments of the present invention are described in detail above. It should be understood that a person skilled in the art can make many modifications and changes based on the concept of the present invention without creative work. Therefore, any technical solution that can be obtained by a person skilled in the art through logical analysis, reasoning or limited experiments based on the concept of the present invention on the basis of the prior art should be within the scope of protection determined by the claims.

Claims

1. A method for preparing a glutamine nano preparation, characterized in that: By weight: Step (1), dissolving 0.5-1.5 parts of an emulsifier in 4-8 parts of anhydrous ethanol, stirring at 60-80° C. for 0.5-1 hour to obtain an emulsifier ethanol solution; Step (2), adding 150-250 parts of gliadin to 1500-2500 parts of 60-80wt% ethanol aqueous solution and stirring for 0.5-1 hour, adding 80-120 parts of polypropylene glycol diglycidyl ether, continuing stirring for 4-6 hours, adding 200-300 parts of N-acetylglucosamine aqueous solution, continuing stirring for 4-6 hours, and finally placing in a dialysis bag for dialysis for 12-48 hours, and freeze-drying to obtain modified gliadin; Step (3), dissolving 200-300 parts of modified gliadin in 2000-3000 parts of 60-80wt% ethanol aqueous solution, mixing with 800-1200 parts of glutamine-water solution, stirring at room temperature for 0.5-1 hour to obtain a mixed suspension solution, adding 8-15 parts of phospholipids, 4-8 parts of emulsifier ethanol solution, and 250-350 parts of glycerol to the mixed suspension solution, stirring at 60-80°C for 1-2 hours until the emulsification is uniform, processing by a high-pressure homogenizer 2-4 times, and finally spray drying to obtain the glutamine nano preparation; In the step (1), the emulsifier is any one or more of caprylic / capric macrogol glyceride, glyceryl phosphate, and glyceryl monolaurate.

2. The method for preparing the glutamine nanoformulation according to claim 1, characterized in that: The N-acetylglucosamine aqueous solution in step (2) is a 5-10 wt % N-acetylglucosamine aqueous solution.

3. The method for preparing the glutamine nanoformulation according to claim 1, characterized in that: The glutamine-water solution in step (3) is 15-25 wt % glutamine-water solution.

4. The method for preparing the glutamine nanoformulation according to claim 1, characterized in that: The phospholipid in step (3) is soybean lecithin.

5. The method for preparing the glutamine nanoformulation according to claim 1, characterized in that: In step (3), the processing parameters of the high pressure homogenizer are 600-1000 bar.

6. The method for preparing the glutamine nanoformulation according to claim 1, characterized in that: The particle size of the glutamine nanoparticle preparation in step (3) is 20-50 nm.

7. A glutamine nano preparation, characterized in that: The compound is prepared by the preparation method according to any one of claims 1 to 6.

8. Use of the glutamine nano preparation as claimed in claim 7 in the preparation of alcohol sobering tablets.

9. The use according to claim 8, characterized in that The hangover-relieving tablet is prepared by tableting the following raw materials: the glutamine nano preparation, a filler, a binder, a sweetener and a lubricant.